Hexokinase-4
Definition:
References:
-
[1]. G Velho, et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest. 1996 Oct 15;98(8):1755-61. [Content Brief]
[2]. Priya Pal, et al. Activating mutations in the human glucokinase gene revealed by genetic selection. Biochemistry. 2009 Feb 10;48(5):814-6. [Content Brief]
[3]. Antonio L Cuesta-Muñoz, et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes. 2004 Aug;53(8):2164-8. [Content Brief]
[4]. L Z Xu, et al. Sugar specificity of human beta-cell glucokinase: correlation of molecular models with kinetic measurements. Biochemistry. 1995 May 9;34(18):6083-92. [Content Brief]
[5]. Henrik B T Christesen, et al. The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy. Diabetes. 2002 Apr;51(4):1240-6. [Content Brief]
[6]. Itziar Estalella, et al. Biochemical characterization of novel glucokinase mutations isolated from Spanish maturity-onset diabetes of the young (MODY2) patients. J Hum Genet. 2008;53(5):460-466. [Content Brief]
[7]. Vladi V Heredia, et al. Biochemical basis of glucokinase activation and the regulation by glucokinase regulatory protein in naturally occurring mutations. J Biol Chem. 2006 Dec 29;281(52):40201-7. [Content Brief]
[8]. Anne Raimondo, et al. Phenotypic severity of homozygous GCK mutations causing neonatal or childhood-onset diabetes is primarily mediated through effects on protein stability. Hum Mol Genet. 2014 Dec 15;23(24):6432-40. [Content Brief]
[9]. J Takeda, et al. Structure/function studies of human beta-cell glucokinase. Enzymatic properties of a sequence polymorphism, mutations associated with diabetes, and other site-directed mutants. J Biol Chem. 1993 Jul 15;268(20):15200-4. [Content Brief]